Pharmaceutical Industry Has Not Made Business Case for Quality
This article was originally published in The Gold Sheet
Executive Summary
The pharmaceutical industry has not made the business case for quality, according to a recent PDA survey. A majority of pharmaceutical manufacturers did not calculate the cost of poor quality, yet many have adopted Six Sigma and similar programs for improving quality.